Body extremities are external articulated organs, which perform different locomotive functions. Leading players are now specializing within the extremity reconstruction market because of the slow growth within the massive joint reconstruction market that features hips and knees. Although the extremities reconstruction market accounts for under a tiny low percentage of the orthopaedic industry, it is the fastest growing marketplace for reconstructive joint replacements.
The global extremity reconstruction market is driven by increase within the quantity of joint disorders such as osteoarthritis and arthritis, increase in the ageing population, and rapid rise in lifestyle related disorders such as obesity and diabetes, which further contribute to joint disorders. In addition, increase in awareness of patients about better treatment options and their desire for better quality of life is expected to further augment the expansion of the extremity reconstruction market.
Changes in clinical practice patterns and advancement of technologies such as reversed shoulder instead of anatomic shoulder, ankle arthroplasty procedure as an alternate to ankle fusion, and development of minimally invasive techniques such as stemless shoulder implants are further expected to drive the market. However, the high cost involved and potential failures and complications arising during and after surgeries are expected to restrain the expansion of the market.
The extremity reconstruction market is segmented by product, material, and geography. On the basis of product, the market is segmented mainly into upper extremity reconstruction and lower extremity reconstruction. The upper extremity reconstruction segment is further sub-segmented into shoulder, elbow, and hand & wrist. The lower extremity reconstruction segment is further segmented into foot & ankle.
Shoulder replacement accounted for the most important market share in 2020, owing to the large patient population, technological advancements in shoulder implants such stemless shoulder implants, and high adoption rates, particularly within the U.S. The ankle replacement market is anticipated to grow at the perfect rate during the forecast period, considering the wonderful clinical outcomes of the procedure.
On the basis of material, the market is segmented into metallic, ceramic, polymer, and natural materials. Metallic materials are extremely strong and are the favored choice of materials for joint replacement, which are expected to possess the best share within the market.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the simplest market share in 2020 followed by Europe. This massive share is primarily attributed to high adoption rate of technologically advanced products. Asia-Pacific is anticipated to witness the simplest rate of growth within the forecast period, primarily because of improving healthcare infrastructure and increase in awareness amongst patients. As the extremity reconstruction market is within the expansion phase, mergers and acquisitions are frequent during this market.
Key players in the market include, DePuy Synthes (a wholly-owned subsidiary of Johnson & Johnson), Stryker Corporation, Smith & Nephew plc., Integra Lifesciences Holdings Corporation, Exatech, Isto Biologics, Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skeletal Dynamics LLC.
The global extremity reconstruction market is driven by increase within the quantity of joint disorders such as osteoarthritis and arthritis, increase in the ageing population, and rapid rise in lifestyle related disorders such as obesity and diabetes, which further contribute to joint disorders. In addition, increase in awareness of patients about better treatment options and their desire for better quality of life is expected to further augment the expansion of the extremity reconstruction market.
Changes in clinical practice patterns and advancement of technologies such as reversed shoulder instead of anatomic shoulder, ankle arthroplasty procedure as an alternate to ankle fusion, and development of minimally invasive techniques such as stemless shoulder implants are further expected to drive the market. However, the high cost involved and potential failures and complications arising during and after surgeries are expected to restrain the expansion of the market.
The extremity reconstruction market is segmented by product, material, and geography. On the basis of product, the market is segmented mainly into upper extremity reconstruction and lower extremity reconstruction. The upper extremity reconstruction segment is further sub-segmented into shoulder, elbow, and hand & wrist. The lower extremity reconstruction segment is further segmented into foot & ankle.
Shoulder replacement accounted for the most important market share in 2020, owing to the large patient population, technological advancements in shoulder implants such stemless shoulder implants, and high adoption rates, particularly within the U.S. The ankle replacement market is anticipated to grow at the perfect rate during the forecast period, considering the wonderful clinical outcomes of the procedure.
On the basis of material, the market is segmented into metallic, ceramic, polymer, and natural materials. Metallic materials are extremely strong and are the favored choice of materials for joint replacement, which are expected to possess the best share within the market.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the simplest market share in 2020 followed by Europe. This massive share is primarily attributed to high adoption rate of technologically advanced products. Asia-Pacific is anticipated to witness the simplest rate of growth within the forecast period, primarily because of improving healthcare infrastructure and increase in awareness amongst patients. As the extremity reconstruction market is within the expansion phase, mergers and acquisitions are frequent during this market.
Key players in the market include, DePuy Synthes (a wholly-owned subsidiary of Johnson & Johnson), Stryker Corporation, Smith & Nephew plc., Integra Lifesciences Holdings Corporation, Exatech, Isto Biologics, Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skeletal Dynamics LLC.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the extremity reconstruction market share, segments, current trends, estimations, and dynamics of the extremity reconstruction market analysis from 2020 to 2030 to identify the prevailing extremity reconstruction market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the extremity reconstruction industry segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the extremity reconstruction industry.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global extremity reconstruction market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Upper Extremity
- Lower Extremity
By Material
- Metallic Material
- Ceramic Material
- Polymeric Material
- Natural Material
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Malaysia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Israel
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- CONMED Corp.
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- depuy synthes
- Integra LifeSciences Holdings Corporation
- Wright Medical Group N.V.
- Acumed, Inc.
- Arthrex, Inc
- Skeletal Dynamics LLC.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT
CHAPTER 5: EXTREMITY RECONSTRUCTION MARKET, BY MATERIAL
CHAPTER 6: EXTREMITY RECONSTRUCTION MARKET, BY REGION
CHAPTER 7: COMPANY LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Extremity Reconstruction Market,' the extremity reconstruction market size was valued at $3.6 billion in 2020, and is estimated to reach $6.5 billion by 2030, growing at a CAGR of 6.3% from 2021 to 2030.The key drivers of the extremity reconstruction market size include, the rise within the number of joint disorders such as osteoarthritis and atrophic arthritis, increase within the ageing population, and rise in prevalence of diabetes and obesity globally, which further contribute to joint disorders. Increase in awareness amongst patients about the advantages of small joint reconstruction devices and improvement of technology such as the event of stemless shoulder implants, reverse shoulder implants, and ankle reconstruction devices help patients to retain the mobility of the ankle, and are expected to propel the growth of the market. However, unfavorable reimbursement scenarios, requirement for revision of the surgery after few years, and complications involved within the extremity reconstruction surgery are expected to hamper the growth of the extremity reconstruction market share.
The extremity reconstruction market analysis is segmented by product, material, and region. On the basis of product, the market is sub-segmented into upper extremity reconstruction devices and lower extremity reconstruction devices. Upper extremity reconstruction devices are further segmented into shoulder reconstruction, elbow reconstruction, and hand & wrist reconstruction. Lower extremity reconstruction is further segmented into foot fusion, ankle fusion, and ankle reconstruction.
Amongst the upper extremity reconstruction devices, shoulder reconstruction is the highest revenue-generating segment within the overall extremity reconstruction market forecast, because of growing number of patients that choose shoulder reconstruction surgery, technological advancements within the shoulder implants, and positive clinical outcomes of shoulder reconstruction surgeries. In the lower extremity reconstruction devices, the ankle replacement sub-segment is predicted to grow at the best rate attributable to the massive number of technological advancements during this area as compared to ankle fusion. Innovations in ankle replacement technology have improved ankle motion in contrast to ankle fusion that restrict motion within the ankles. On the basis of material, the market is segmented into metallic, ceramic, polymer, and natural materials. The natural material segment is predicted to grow at the best rate because it is biocompatible and biodegradable.
KEY FINDINGS OF STUDY
- In 2020, upper extremity reconstruction was the highest revenue-generating segment, and is projected to grow at a CAGR of 6.0 % during the forecast period.
- Metallic materials are the major components of extremity reconstruction market growth.
- The ceramic material extremity reconstruction market was valued at $203.3 million in 2020, and is projected to reach $441.57 million by 2030, registering a CAGR of 8.2% from 2021 to 2030
- The U.S. is the leading country in global extremity reconstruction industry, which accounts for more than 4.3 % of the overall market.
- Germany accounted for about one-third share of the European extremity reconstruction industry in 2020.
- The Indian extremity reconstruction market is expected to grow at a CAGR of 10.7% during the study period.
Companies Mentioned
- CONMED Corp.
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- depuy synthes
- Integra LifeSciences Holdings Corporation
- Wright Medical Group N.V.
- Acumed, Inc.
- Arthrex, Inc
- Skeletal Dynamics LLC.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
